<h3>Overview</h3>
<p>The <strong>U.S. Ambassador to India, Sergio Gor</strong> met <strong>Union Minister Dr. Jitendra Singh</strong> to discuss deeper collaboration across several high‑technology domains. The talks covered skill development, investment, knowledge exchange and industry‑led partnerships in biotechnology, <span class="key-term" data-definition="Quantum technologies – tools that use quantum mechanics for computing, communication, sensing and metrology; a priority area in India’s science agenda (GS3: Science & Technology)">quantum technologies</span>, space, atomic energy and nuclear medicine.</p>
<h3>Key Developments</h3>
<ul>
<li>India opened the <span class="key-term" data-definition="Nuclear medicine – medical specialty that uses radioactive substances for diagnosis and therapy, now open to private sector participation (GS3: Science & Technology)">nuclear medicine</span> research to private players, creating new investment avenues.</li>
<li>Four thematic hubs under the <span class="key-term" data-definition="National Quantum Mission – a government programme to develop quantum computing, communication, sensing, metrology and materials; India has achieved over half its targets in three years (GS3: Science & Technology)">National Quantum Mission</span> are operational, with progress exceeding the eight‑year plan.</li>
<li>The <span class="key-term" data-definition="U.S.-India TRUST initiative – a bilateral framework for trusted technology cooperation covering AI, semiconductors, quantum, biotech, energy, advanced materials and space (GS3: Science & Technology)">U.S.-India TRUST initiative</span> will guide joint work among governments, academia, industry and start‑ups.</li>
<li>The <span class="key-term" data-definition="Research, Development and Innovation Fund (RDIF) – a government fund offering long‑term, low‑interest financing to private firms for R&D, encouraging equal partnership in innovation (GS3: Economy)">Research, Development and Innovation Fund</span> was highlighted as a financing tool for private sector R&D.</li>
<li>Proposal for a regular working group (possibly monthly) to coordinate investment, skilling and knowledge exchange with U.S. investors.</li>
<li>Discussions on leveraging India’s diverse genetic data pool for global biotech research, AI‑enabled diagnostics, vaccine cooperation and CAR‑T therapy trials.</li>
</ul>
<h3>Important Facts</h3>
<p>India’s large, heterogeneous genetic pool offers a unique advantage for precision medicine and AI‑driven diagnostics. The Minister noted that AI‑enabled sequencing can cut diagnostic time from the conventional 48 hours to a few hours. Private sector entry into nuclear research is expected to be formalised in the coming weeks, with safeguards in place. Existing platforms such as <strong>IUSSTF</strong>, <strong>USISTEF</strong> and collaborations with the U.S. National Science Foundation will support implementation.</p>
<h3>UPSC Relevance</h3>
<p>These development
Loading page, please wait…